Literature DB >> 8693420

Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?

C C Wu1, W L Ho, D C Yeh, C R Huang, T J Liu, F K P'eng.   

Abstract

BACKGROUND: Resection for hepatocellular carcinoma in patients with cirrhosis and impaired liver function is usually unjustified because of higher surgical risks and poorer long-term prognosis.
METHODS: A retrospective comparison of the background and resectional results of patients with cirrhosis and hepatocellular carcinoma was carried out between those with preoperative indocyanine green 15-minute retention rate of 20% or greater (group A, impaired function group, n = 36) and those with indocyanine green 15-minute retention rate of 10% or less (group B, normal function group, n = 34).
RESULTS: The group A patients had significantly lower serum albumin level and higher serum bilirubin level, longer prothrombin time, higher incidence of associated esophageal varices, and poorer Child's classifications for cirrhosis. Although the tumor diameter in both groups was similar (A, 6.9 versus B, 7.1 cm; p = 0.94), the resected liver amount in group B was greater (227.4 versus 473.2 gm; p = 0.038) because of a greater extent of liver resection (p < 0.001) and a wider surgical margin (0.34 versus 1.85 cm; p < 0.0001). The amount of operative blood loss and blood transfusion, operative morbidity, and operative mortality were not different between the two groups. The pathologic characteristics and staging were also comparable. The 5-year disease-free and actuarial survival rates of groups A and B were 30.9% and 29.6% (p = 0.16) and 45.2% and 33.4% (p = 0.11), respectively.
CONCLUSIONS: If the amount of resected nontumorous liver parenchyma could be reduced, resection of hepatocellular carcinoma in selected patients with cirrhosis and impaired liver function is still justified in spite of a narrow surgical margin.

Entities:  

Mesh:

Year:  1996        PMID: 8693420     DOI: 10.1016/s0039-6060(96)80238-8

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

3.  The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.

Authors:  Min-Che Lin; Cheng-Chung Wu; Shao-Bin Cheng; Tse-Jia Liu; Fang-Ku P'eng
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

Review 4.  Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

5.  Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma.

Authors:  C M Lo; E C Lai; C L Liu; S T Fan; J Wong
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

Review 6.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

7.  Liver tissue sparing resection using a novel planning tool.

Authors:  Frank Pianka; Matthias Baumhauer; Daniel Stein; Boris Radeleff; Bruno M Schmied; Hans-Peter Meinzer; Sascha A Müller
Journal:  Langenbecks Arch Surg       Date:  2010-12-16       Impact factor: 3.445

Review 8.  Practical considerations in the treatment of hepatocellular carcinoma.

Authors:  M Colleoni; R A Audisio; F De Braud; N Fazio; G Martinelli; A Goldhirsch
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

9.  Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma.

Authors:  Shoji Kubo; Tadashi Tsukamoto; Kazuhiro Hirohashi; Hiromu Tanaka; Taichi Shuto; Shigekazu Takemura; Takatsugu Yamamoto; Takahiro Uenishi; Masao Ogawa; Hiroaki Kinoshita
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

10.  Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.

Authors:  Uta Merle; Olivia Sieg; Wolfgang Stremmel; Jens Encke; Christoph Eisenbach
Journal:  BMC Gastroenterol       Date:  2009-12-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.